X4 Pharmaceuticals, Inc. (XFOR)

X4 Pharmaceuticals Revenue

In the year 2025, X4 Pharmaceuticals had annual revenue of $35.11M with 1,273.21% growth. X4 Pharmaceuticals had revenue of $2.57M in the quarter ending December 31, 2025, with 79.08% growth.

• Revenue (ttm): $35.11M
• Revenue Growth: +1,273.21%
• P/S Ratio: 11.11
• Revenue / Employee: $780,289
• Employees: 45
• Market Cap: 390.05M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	35.11M	32.56M	1,273.21%
Dec 31, 2024	2.56M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-